Cargando…
Using Fragment-Based Approaches to Discover New Antibiotics
Fragment-based lead discovery has emerged over the past two decades as a successful approach to generate novel lead candidates in drug discovery programs. The two main advantages over conventional high-throughput screening (HTS) are more efficient sampling of chemical space and tighter control over...
Autores principales: | Lamoree, Bas, Hubbard, Roderick E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024353/ https://www.ncbi.nlm.nih.gov/pubmed/29923463 http://dx.doi.org/10.1177/2472555218773034 |
Ejemplares similares
-
Current perspectives in fragment-based lead discovery (FBLD)
por: Lamoree, Bas, et al.
Publicado: (2017) -
Fragment approaches in structure-based drug discovery
por: Hubbard, Roderick E.
Publicado: (2008) -
The future of antibiotics begins with discovering new combinations
por: Zhu, Meilin, et al.
Publicado: (2021) -
A novel method to discover fluoroquinolone antibiotic resistance (qnr) genes in fragmented nucleotide sequences
por: Boulund, Fredrik, et al.
Publicado: (2012) -
E3 Ligases
Meet Their Match: Fragment-Based Approaches
to Discover New E3 Ligands and to Unravel E3 Biology
por: Michaelides, Iacovos N., et al.
Publicado: (2023)